Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 60,073 shares at $37.41 ($2.3M) on 2025-01-16, disclosed to the SEC on 2025-01-21.
Scheduled sale ($2.3M) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.41 | 29,475 | $1.1M | 49.0% |
| 2 | $37.41 | 29,475 | $1.1M | 49.0% |
| 3 | $40.00 | 1,123 | $45K | 2.0% |
| Total | $37.46 avg | 60,073 | $2.3M | 100% |
| Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |
| HRMY | SELL | 2024-10-31 | $1.7M | — | Filing → |